|
|
|
|
||
SPY Elite and DermACELL: Bridging the Gap between Breast and Plastic Surgeons to Improve Breast ReconstructionListened to and watched the web presentation yesterday. Technically outstanding for surgeons but for the average investor a little bit too far in the weeds. Drip, drip, drip....the evidence is building for the integration of DermACELL, Onocologic surgeons, Sentinal Lymph Nod Mapping, and plastic reconstruction to work together for the patient outcome and significant savings for the health payers. $149,000@ to correct surgery gone bad on average. The tie between all of the integration is the Spy technology. Without it either the surgery cannot be done or must be done in multiple steps. If the results don't turn out then there is "finger" pointing between the onocological and reconstructive camps. Spy eliminates ~100% of the conflict. Almost all the time ~97% because there are no failures to choose the correct surgical plan and with confirmation real time to have successful blood perfusion and removal of the cancer (boundary definition and lymph nod mapping). A case for DermACELL versus Aloderm was also made very emphatically. I will not tolerate "Red Breast Syndrome" and since I switched to DermACELL there have been "Zero cases"! Excellent web presentation of an integrated, technically superior process--definitely "Best in Class" methodology and painfully evident presentation when things go wrong. Drip, drip, drip... Can be accessed on the Novadaq web site under Investors / Events GSA |
return to message board, top of board |